Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial.
rct · Level I
Where this comes from
- Record sourced from PubMed, PMID 30561577.
- Also identified by DOI 10.1093/cid/ciy973 and PMC identifier 6541729.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In a large community-randomized trial, biannual azithromycin distributions significantly reduced postneonatal childhood mortality in sub-Saharan African sites. Here, we present a prespecified secondary analysis showing that much of the protective effect was in the first 3 months postdistribution. Distributing more frequently than biannually could be considered if logistically feasible. Clinical Trials Registration. NCT02047981.
Medical subject headings
- Anti-Bacterial Agents
- Azithromycin
- Child Mortality
- Trachoma